- Home
- DJTWW vs AMLX Comparison
DJTWW vs AMLX Comparison
Compare DJTWW & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJTWW
- AMLX
- Stock Information
- Founded
- DJTWW 2021
- AMLX 2014
- Country
- DJTWW United States
- AMLX United States
- Employees
- DJTWW 29
- AMLX N/A
- Industry
- DJTWW Computer Software: Programming Data Processing
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- DJTWW Technology
- AMLX Health Care
- Exchange
- DJTWW Nasdaq
- AMLX Nasdaq
- Market Cap
- DJTWW 1.4B
- AMLX 1.3B
- IPO Year
- DJTWW N/A
- AMLX 2022
- Fundamental
- Price
- DJTWW $5.30
- AMLX $12.55
- Analyst Decision
- DJTWW
- AMLX Strong Buy
- Analyst Count
- DJTWW 0
- AMLX 7
- Target Price
- DJTWW N/A
- AMLX $17.43
- AVG Volume (30 Days)
- DJTWW 172.0K
- AMLX 1.6M
- Earning Date
- DJTWW 04-02-2025
- AMLX 11-06-2025
- Dividend Yield
- DJTWW N/A
- AMLX N/A
- EPS Growth
- DJTWW N/A
- AMLX N/A
- EPS
- DJTWW N/A
- AMLX N/A
- Revenue
- DJTWW $3,369,800.00
- AMLX N/A
- Revenue This Year
- DJTWW N/A
- AMLX N/A
- Revenue Next Year
- DJTWW N/A
- AMLX N/A
- P/E Ratio
- DJTWW N/A
- AMLX N/A
- Revenue Growth
- DJTWW N/A
- AMLX N/A
- 52 Week Low
- DJTWW $6.53
- AMLX $2.60
- 52 Week High
- DJTWW $44.83
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- DJTWW 19.13
- AMLX 42.87
- Support Level
- DJTWW $5.55
- AMLX $11.93
- Resistance Level
- DJTWW $6.50
- AMLX $12.79
- Average True Range (ATR)
- DJTWW 0.39
- AMLX 0.71
- MACD
- DJTWW -0.03
- AMLX -0.22
- Stochastic Oscillator
- DJTWW 5.85
- AMLX 30.92
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.